Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

10.7%

17 terminated/withdrawn out of 159 trials

Success Rate

88.7%

+2.2% vs industry average

Late-Stage Pipeline

28%

44 trials in Phase 3/4

Results Transparency

46%

62 of 134 completed trials have results

Key Signals

62 with results15 terminated

Enrollment Performance

Analytics

Phase 1

52(35.9%)

Phase 2

42(29.0%)

Phase 3

37(25.5%)

Phase 4

7(4.8%)

N/A

6(4.1%)

Early Phase 1

1(0.7%)

145Total

Phase 1(52)

Phase 2(42)

Phase 3(37)

Phase 4(7)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (159)

Showing 20 of 159 trials

NCT01114269Active Not Recruiting

PRE-DETERMINE Cohort Study

Role: collaborator

NCT02674347Phase 1Completed

MAD Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Intravenous Zidebactam in Healthy Adults

Role: collaborator

NCT02998450Phase 1Completed

A Study of IMR-687 in Healthy Adult Volunteers

Role: collaborator

NCT01422434Phase 3Completed

LEO 90105 Ointment in Japanese Subjects With Psoriasis

Role: collaborator

NCT01293383Phase 1Completed

A Study Evaluating the Safety of LEO 90105 and Its Vehicle, After Multiple Administration on Intact Skin of Healthy Japanese Male Subjects

Role: collaborator

NCT01293357Phase 1Completed

A Study Evaluating Skin Irritation, Phototoxicity and Safety After Administration of LEO 90105 on Intact Skin of Healthy Japanese Male Subjects

Role: collaborator

NCT00400179Phase 3Completed

A Safety and Efficacy Study in Patients With Gastric Cancer

Role: collaborator

NCT00687596Phase 2Terminated

Study of TAC-101 as Second Line Treatment in Patients With Advanced Hepatocellular Carcinoma Who Received Sorafenib as First Line Therapy

Role: collaborator

NCT00651742Phase 2Completed

Phase 2 Study of S-1 in Advanced or Metastatic Pancreatic Cancer

Role: collaborator

NCT03215056Phase 3Completed

Methoxyflurane Analgesia for Paediatric Injuries

Role: collaborator

NCT00667628Phase 2Terminated

Phase 2 Study of TAC-101 Combined With Transcatheter Arterial Chemoembolization (TACE) Versus TACE Alone in Japanese Patients With Advanced Hepatocellular Carcinoma

Role: collaborator

NCT02025803Phase 1Completed

A Safety, Tolerability and Pharmacokinetic Study of TAS-114 in Combination With Capecitabine in Patients With Advanced Solid Tumors

Role: collaborator

NCT00651833Phase 2Completed

Phase 2 Study of S-1 in Combination With Cisplatin as 1st Line Therapy in Advanced Non-Small Cell Lung Cancer

Role: collaborator

NCT00652561Phase 2Completed

Phase 2 Study of S-1 as 2nd Line Therapy in Advanced Non-Small Cell Lung Cancer

Role: collaborator

NCT00652054Phase 2Completed

Phase 2 Study of S-1 as 2nd Line Therapy in Metastatic Pancreatic Cancer

Role: collaborator

NCT02965573Phase 2Completed

A Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of ARGX-113 in Patients With Myasthenia Gravis Who Have Generalized Muscle Weakness

Role: collaborator

NCT01664078Not ApplicableCompleted

A Multicenter, Open Label, Prospective, Non-randomized Study of the InCraft® Stent Graft System in Subjects With Abdominal Aortic Aneurysms (INSPIRATION)

Role: collaborator

NCT00552110Phase 2Completed

Study of Mometasone Furoate Nasal Spray and Oxymetazoline Nasal Spray Given Together Once A Day To Treat Seasonal Allergic Rhinitis (P04500)

Role: collaborator

NCT02061358Phase 1Completed

Study to Determine the Safety, Tolerability and Pharmacokinetics of UV-4B Solution Administered Orally in Healthy Subjects

Role: collaborator

NCT02923947Phase 1Completed

Study to Assess Osimertinib in Patients w/ Adv Solid Tumours & Normal Kidney Function or Severe Kidney Impairment

Role: collaborator